ReSearch
{{ mc.sd.lang | uppercase }}
Long-term follow-up of endovascular treatment for trans-atlantic inter-society consensus II type B iliac lesions in patients aged <50 years
Radak, Đorđe
Babić, Srđan
Sagić, Dragan
Antonić, Zelimir
Kovačević, Vladimir
Stevanović, Predrag
Tanasković, Slobodan
Sotirović, Vuk
Otašević, Petar
BACKGROUND: To study the initial and long-term results of endovascular treatment in patients aged <50 years with Trans-Atlantic Inter-Society Consensus-II type B unilateral iliac lesions and chronic limb ischemia. METHODS: From January 2000 to February 2010, 60 consecutive endovascular interventions were performed on 23 women and 37 men aged 50 years. After successful treatment, all patients were followed up at 1, 3, 6, and 12 months after the procedure and every 6 months thereafter. RESULTS: Successful percutaneous revascularization of the iliac artery was achieved in 56 patients (93.3%). The early vascular-related complication rate was 6.7%. The primary patency rates at 1, 3, and 5 years were 88%, 59%, and 49%, respectively. Cox univariate analysis revealed that an age range of 45 to 50 years (hazard ratio [HR]: 0.290; 95% confidence interval [CI]: 0.152e0.553; P ¼ 0.0001), lower preprocedural ankle-brachial index (HR: 2.438; 95% CI: 1.04e5.715; P ¼ 0.047), lesion length >5 cm (HR: 0.838; 95% CI: 0.746e0.943; P ¼ 0.003), and diabetes (HR: 2.005; 95% CI: 1.010e3.980; P ¼ 0.047) had significant influence on decreasing primary patency. CONCLUSION: Endovascular treatment of TASC-II type B iliac lesions in patients aged <50 years is a safe procedure with low procedural risk. Primary patency rates at 1, 3, and 5 years were 88%, 59%, and 49%, respectively.
engleski
2012
Ovo delo je licencirano pod uslovima licence
Creative Commons CC BY-NC-ND 4.0 - Creative Commons Autorstvo - Nekomercijalno - Bez prerada 4.0 International License.
Podatak o licenci prema https://v2.sherpa.ac.uk/id/publication/10584
10.1016/j.avsg.2011.09.008
126453769